Health News

A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an antileprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases.

Read more

Filed under: Pharmacy News
Tags: Drug, medicine, Pharmacy, sclerosis, Tuberculosis

Related posts

• Teaching an Old Drug New Tricks (0)
  A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an antileprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases. Read more [tags] Pharmacy News [/tags]
  
  
• US FDA Approves Extavia(R) - The First In A New Portfolio Of Planned MS Therapies From Novartis To Help Patients With This Devastating Disease (0)
  The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease. Extavia is approved by the FDA for the treatment of relapsing forms of MS to reduce the frequency of [...]
  
  
• Teaching an old drug new tricks (0)
  (Johns Hopkins Medical Institutions) A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an anti-leprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases. Read more [tags] General Health News [/tags]
  
  
• TB medication variations in private markets could harm treatment efforts, study says (0)
  A wide variation in the dosages and forms of medicines prescribed by private physicians to patients with tuberculosis in developing countries could lead to the development of more drug-resistant strains of the bacterial infection, according to a study published online Wednesday in PLoS One, the Financial Times reports. Read more [tags] Pharmacy News [/tags]
  
  
• Study In NEJM Shows Novartis Drug Afinitor® Reduces Size Of SEGAs, Benign Brain Tumors Associated With Tuberous Sclerosis (0)
  The New England Journal of Medicine (NEJM) published a study that found patients taking Afinitor® (everolimus) tablets experienced a decrease in the size of their subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated with tuberous sclerosis (TS)(1,2)... Read more [tags] Pharmacy News [/tags]